Published April 14, 2023
| Version v1
Journal article
Open
First-in-class ultralong target residence time p38α inhibitors as a novel mitosis-targeted therapy for colorectal cancer
Authors/Creators
- 1. 1Department of Medical Oncology and Pneumology, University Hospital Tuebingen, Tuebingen, Germany 2IFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. 3Department of Pharmaceutical Chemistry, University of Tuebingen, Tuebingen, Germany, 4School of Pharmacy, University of Eastern Finland, Kuopio, Finland
Description
PDB file for the proposed binding of compound 1639 in the Human p38alpha structure. Associated methods are provided in the respective publication
Files
Files
(6.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ed6ed38bbe3fa072f9e566dfb3355abf
|
470.3 kB | Download |
|
md5:d177eb41242a4eb33c911e8b5df21d11
|
6.4 MB | Download |